chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Urinary tract infection
Clinical narrative: left arm hurting; some headache.; started taking cefuroxime, for urinary infection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (left arm hurting), HEADACHE (some headache.) and URINARY TRACT INFECTION (started taking cefuroxime, for urinary infection) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Diabetes. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and FISH OIL for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced URINARY TRACT INFECTION (started taking cefuroxime, for urinary infection). On an unknown date, the patient experienced PAIN (left arm hurting) and HEADACHE (some headache.). At the time of the report, PAIN (left arm hurting), HEADACHE (some headache.) and URINARY TRACT INFECTION (started taking cefuroxime, for urinary infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details was included Cefuroxime
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Myalgia
Clinical narrative: fever 101; intense body aches all over; chills; nasty headache; extreme fatigue; really miserable; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache) and FATIGUE (extreme fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LAMOTRIGINE for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache), FATIGUE (extreme fatigue) and FEELING ABNORMAL (really miserable). At the time of the report, PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache), FATIGUE (extreme fatigue) and FEELING ABNORMAL (really miserable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Aleve (Naproxen).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever 101; intense body aches all over; chills; nasty headache; extreme fatigue; really miserable; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache) and FATIGUE (extreme fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LAMOTRIGINE for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache), FATIGUE (extreme fatigue) and FEELING ABNORMAL (really miserable). At the time of the report, PYREXIA (fever 101), MYALGIA (intense body aches all over), CHILLS (chills), HEADACHE (nasty headache), FATIGUE (extreme fatigue) and FEELING ABNORMAL (really miserable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Aleve (Naproxen).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Rash, Urticaria
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives/Urticaria), RASH (Rash), PRURITUS (Itchiness), ERYTHEMA (Redness) and PERIPHERAL SWELLING (swollen arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  Concurrent medical conditions included Hypertension, Cholesterol, Thyroid disorder and Contrast media allergy (Rash on arm-large and itchy). Concomitant products included METOPROLOL SUCCINATE, ROSUVASTATIN, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) and HCTZ for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PRURITUS (Itchiness), ERYTHEMA (Redness) and PERIPHERAL SWELLING (swollen arm). On an unknown date, the patient experienced URTICARIA (Hives/Urticaria) and RASH (Rash). On 28-Feb-2021, URTICARIA (Hives/Urticaria), PRURITUS (Itchiness), ERYTHEMA (Redness) and PERIPHERAL SWELLING (swollen arm) had resolved. At the time of the report, RASH (Rash) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information were not provided. Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Additional information received and reporter information was updated On 18-Jul-2021: Patient Medical history,Concomitant medication were added.Events Hives, Rash were added.EventsItchiness,redness,Swollen arm outcome was changed from Unknown to Recovered.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: itchy; redness which got bigger; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 20-Feb-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of PRURITUS (itchy) and ERYTHEMA (redness which got bigger) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ERYTHEMA (redness which got bigger). On 19-Feb-2021, the patient experienced PRURITUS (itchy). At the time of the report, PRURITUS (itchy) and ERYTHEMA (redness which got bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was included Tylenol.   Reporter did not allow further contact
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pain
Clinical narrative: body aches; flu-like symptoms; chills; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021. The most recent information was received on 14-Jul-2021 and was forwarded to Moderna on 14-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN (body aches), INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills). At the time of the report, PAIN (body aches) had not resolved and INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided.  No treatment information were provided.  At the time of follow up the patient was in pain.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Updated outcome of the event of body aches.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Pyrexia
Clinical narrative: Swollen glands under the arm; Fever; Headache; A spontaneous reportwas received from a consumer concerning a 43-Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever, headache and swollen glands under the arm.  The patient's medical history included COVID-19. No relevant concomitant medications were reported.    On 15 Jan 2021, 2 days prior to the onset of the events fever and headache the patient received their first of two planned doses of mRNA-1273 (039K20A) in right arm for prophylaxis of COVID-19 infection.  On 16 Jan 2021, the patient experienced fever and headache. On 21 Jan 2021, the patient had swollen glands under the arm.  Treatment for the event included Motrin.  Action taken with mRNA-1273 in response to the event was not reported.  On 17 Jan 2021, the outcome of the event fever was resolved. On 19 Jan 2021, The outcome of the event headache was resolved. On 24 Jan 2021, the outcome of the event swollen glands under the arm was resolved.; Reporter's Comments: This case concerns a 43-year-old female, with medical history of COVID-19, who experienced nonserious expected events of fever, headache, and lymphadenopathy. The events occurred 2 days after the first dose of mRNA-1273. Treatment included Motrin. Event outcomes reported as resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscle spasms, Myalgia, Pain in extremity, Paraesthesia
Clinical narrative: Sore left arm; muscle aches in my upper arms; back spasms; numbness in both hands; tingling in both hands; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore left arm), MYALGIA (muscle aches in my upper arms), MUSCLE SPASMS (back spasms), HYPOAESTHESIA (numbness in both hands) and PARAESTHESIA (tingling in both hands) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included MGUS.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm), MYALGIA (muscle aches in my upper arms), MUSCLE SPASMS (back spasms), HYPOAESTHESIA (numbness in both hands) and PARAESTHESIA (tingling in both hands). At the time of the report, PAIN IN EXTREMITY (Sore left arm), MYALGIA (muscle aches in my upper arms), MUSCLE SPASMS (back spasms), HYPOAESTHESIA (numbness in both hands) and PARAESTHESIA (tingling in both hands) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Pain, Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: Soreness; The entire arm is hot touch; Hardness; Swelling; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), INJECTION SITE WARMTH (The entire arm is hot touch), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Soreness), INJECTION SITE WARMTH (The entire arm is hot touch), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, PAIN (Soreness), INJECTION SITE WARMTH (The entire arm is hot touch), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up was received. Outcome of all events were updated to recovered/resolved. Reporter declined further follow-up. It contains significant information.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Decreased appetite, Gait disturbance
Clinical narrative: Chills; not have appetite,; have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder; have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder; has more trouble walking,; felt sleepy; has a bump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), DECREASED APPETITE (not have appetite,), CHEST PAIN (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), CHEST DISCOMFORT (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder) and GAIT DISTURBANCE (has more trouble walking,) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ROSUVASTATIN, CALCIUM, IRON (CALCIUM & IRON), MECLIZINE HCL, CLONAZEPAM and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced CHILLS (Chills), DECREASED APPETITE (not have appetite,), CHEST PAIN (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), CHEST DISCOMFORT (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), GAIT DISTURBANCE (has more trouble walking,), SOMNOLENCE (felt sleepy) and INJECTION SITE MASS (has a bump at the injection site). The patient was treated with PARACETAMOL (TYLENOL 8 HOUR) at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), DECREASED APPETITE (not have appetite,), CHEST PAIN (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), CHEST DISCOMFORT (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), GAIT DISTURBANCE (has more trouble walking,), SOMNOLENCE (felt sleepy) and INJECTION SITE MASS (has a bump at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Somnolence
Clinical narrative: Chills; not have appetite,; have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder; have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder; has more trouble walking,; felt sleepy; has a bump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), DECREASED APPETITE (not have appetite,), CHEST PAIN (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), CHEST DISCOMFORT (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder) and GAIT DISTURBANCE (has more trouble walking,) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ROSUVASTATIN, CALCIUM, IRON (CALCIUM & IRON), MECLIZINE HCL, CLONAZEPAM and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced CHILLS (Chills), DECREASED APPETITE (not have appetite,), CHEST PAIN (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), CHEST DISCOMFORT (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), GAIT DISTURBANCE (has more trouble walking,), SOMNOLENCE (felt sleepy) and INJECTION SITE MASS (has a bump at the injection site). The patient was treated with PARACETAMOL (TYLENOL 8 HOUR) at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), DECREASED APPETITE (not have appetite,), CHEST PAIN (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), CHEST DISCOMFORT (have chest pain, it feels like heavy chest patient had experienced this symptom before the vaccine, but this one is a bit harder), GAIT DISTURBANCE (has more trouble walking,), SOMNOLENCE (felt sleepy) and INJECTION SITE MASS (has a bump at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: couldn't go to work; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 20-Feb-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (couldn't go to work) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (couldn't go to work). At the time of the report, VACCINATION COMPLICATION (couldn't go to work) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Decreased appetite, Fatigue, Malaise
Clinical narrative: not feeling well; cannot eat, and has no appetite; Fatigue; Sick to her stomach; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FATIGUE (Fatigue), ABDOMINAL DISCOMFORT (Sick to her stomach), MALAISE (not feeling well) and DECREASED APPETITE (cannot eat, and has no appetite) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced FATIGUE (Fatigue) and ABDOMINAL DISCOMFORT (Sick to her stomach). On an unknown date, the patient experienced MALAISE (not feeling well) and DECREASED APPETITE (cannot eat, and has no appetite). At the time of the report, FATIGUE (Fatigue), ABDOMINAL DISCOMFORT (Sick to her stomach), MALAISE (not feeling well) and DECREASED APPETITE (cannot eat, and has no appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Headache, Oropharyngeal pain
Clinical narrative: Very Uncomfortable; Sore Throat; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Very Uncomfortable), OROPHARYNGEAL PAIN (Sore Throat) and HEADACHE (Headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced DISCOMFORT (Very Uncomfortable), OROPHARYNGEAL PAIN (Sore Throat) and HEADACHE (Headache). At the time of the report, DISCOMFORT (Very Uncomfortable), OROPHARYNGEAL PAIN (Sore Throat) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Contusion, Myalgia, Oropharyngeal pain, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain) and PYREXIA (fever of 99-100 degrees) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain), PYREXIA (fever of 99-100 degrees) and ARTHRALGIA (Bruised area of hip and pain in right hip). At the time of the report, PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain), PYREXIA (fever of 99-100 degrees) and ARTHRALGIA (Bruised area of hip and pain in right hip) outcome was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain) and PYREXIA (fever of 99-100 degrees) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain), PYREXIA (fever of 99-100 degrees) and ARTHRALGIA (Bruised area of hip and pain in right hip). At the time of the report, PAIN IN EXTREMITY (Whole left arm hurt really bad), OROPHARYNGEAL PAIN (Slight sore throat), CONTUSION (Bruised area of hip and pain in right hip), MYALGIA (muscle spasms and arm pain), PYREXIA (fever of 99-100 degrees) and ARTHRALGIA (Bruised area of hip and pain in right hip) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site rash
Clinical narrative: rash itched; Broke out into a rash the circumference of a tennis ball around the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash itched) and VACCINATION SITE RASH (Broke out into a rash the circumference of a tennis ball around the vaccination site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced RASH PRURITIC (rash itched) and VACCINATION SITE RASH (Broke out into a rash the circumference of a tennis ball around the vaccination site). On 17-Feb-2021, RASH PRURITIC (rash itched) and VACCINATION SITE RASH (Broke out into a rash the circumference of a tennis ball around the vaccination site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: contact information updated
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Asthma, Chest discomfort, Dizziness, Heart rate
Clinical narrative: Tightness in chest; rapid heart rate (90-115bpm); Lightheaded, dizzy; Nasal discharge (runny nose); asthma exacerbation; Generally weak; Right arm was a little red at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST DISCOMFORT (Tightness in chest), HEART RATE INCREASED (rapid heart rate (90-115bpm)), DIZZINESS (Lightheaded, dizzy), RHINORRHOEA (Nasal discharge (runny nose)) and ASTHMA (asthma exacerbation) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pollen allergy, Sulfonamide allergy and Asthma (mild-intermittent and normally only occurs with seasonal allergies, smoke or upper respiratory infections.).   On 08-Jan-2021 at 3:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced CHEST DISCOMFORT (Tightness in chest), HEART RATE INCREASED (rapid heart rate (90-115bpm)), DIZZINESS (Lightheaded, dizzy), RHINORRHOEA (Nasal discharge (runny nose)), ASTHMA (asthma exacerbation), ASTHENIA (Generally weak) and VACCINATION SITE ERYTHEMA (Right arm was a little red at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site erythema, at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) for Adverse event, at an unspecified dose and frequency. On 08-Jan-2021, HEART RATE INCREASED (rapid heart rate (90-115bpm)) had resolved. On 21-Feb-2021, CHEST DISCOMFORT (Tightness in chest), RHINORRHOEA (Nasal discharge (runny nose)), ASTHMA (asthma exacerbation) and ASTHENIA (Generally weak) had resolved. At the time of the report, DIZZINESS (Lightheaded, dizzy) and VACCINATION SITE ERYTHEMA (Right arm was a little red at the injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Heart rate: 100-115 bpm (High) 100-115 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient visited the physician on 13-Jan-2021 and 02-Feb-2021 as she could not get asthma under control. She started using inhalers as soon as the asthma started and this continued through the end of February. Concomitant medications were not provided.     Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Contact information, patient demographics,medical history, product and event information updated.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Rhinorrhoea, Vaccination site erythema
Clinical narrative: Tightness in chest; rapid heart rate (90-115bpm); Lightheaded, dizzy; Nasal discharge (runny nose); asthma exacerbation; Generally weak; Right arm was a little red at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST DISCOMFORT (Tightness in chest), HEART RATE INCREASED (rapid heart rate (90-115bpm)), DIZZINESS (Lightheaded, dizzy), RHINORRHOEA (Nasal discharge (runny nose)) and ASTHMA (asthma exacerbation) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pollen allergy, Sulfonamide allergy and Asthma (mild-intermittent and normally only occurs with seasonal allergies, smoke or upper respiratory infections.).   On 08-Jan-2021 at 3:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced CHEST DISCOMFORT (Tightness in chest), HEART RATE INCREASED (rapid heart rate (90-115bpm)), DIZZINESS (Lightheaded, dizzy), RHINORRHOEA (Nasal discharge (runny nose)), ASTHMA (asthma exacerbation), ASTHENIA (Generally weak) and VACCINATION SITE ERYTHEMA (Right arm was a little red at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site erythema, at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) for Adverse event, at an unspecified dose and frequency. On 08-Jan-2021, HEART RATE INCREASED (rapid heart rate (90-115bpm)) had resolved. On 21-Feb-2021, CHEST DISCOMFORT (Tightness in chest), RHINORRHOEA (Nasal discharge (runny nose)), ASTHMA (asthma exacerbation) and ASTHENIA (Generally weak) had resolved. At the time of the report, DIZZINESS (Lightheaded, dizzy) and VACCINATION SITE ERYTHEMA (Right arm was a little red at the injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Heart rate: 100-115 bpm (High) 100-115 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient visited the physician on 13-Jan-2021 and 02-Feb-2021 as she could not get asthma under control. She started using inhalers as soon as the asthma started and this continued through the end of February. Concomitant medications were not provided.     Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Contact information, patient demographics,medical history, product and event information updated.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Delusional disorder, unspecified type, Dizziness, Pyrexia
Clinical narrative: Sounding Delusional; Felt Dizzy; Running a Fever; This spontaneous case was reported by a consumer and describes the occurrence of DELUSIONAL DISORDER, UNSPECIFIED TYPE (Sounding Delusional), DIZZINESS (Felt Dizzy) and PYREXIA (Running a Fever) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 025j20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced DELUSIONAL DISORDER, UNSPECIFIED TYPE (Sounding Delusional), DIZZINESS (Felt Dizzy) and PYREXIA (Running a Fever). At the time of the report, DELUSIONAL DISORDER, UNSPECIFIED TYPE (Sounding Delusional) and DIZZINESS (Felt Dizzy) outcome was unknown and PYREXIA (Running a Fever) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.6 (High) increased and 98 (normal) normal.         On 19 Feb 2021, after the second dose of vaccination, patient felt almost like alzheimers, dizzy, running a fever, sounding delusional and having a hard time. Patient experienced a temperature of 100.6 which came down to 98 degrees. Treatment information included tylenol to bring down the fever. Company comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dysphonia, Fatigue, Vision blurred
Clinical narrative: change in voice; blurry vision; light headed; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurry vision), DIZZINESS (light headed), FATIGUE (fatigue) and DYSPHONIA (change in voice) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VISION BLURRED (blurry vision), DIZZINESS (light headed) and FATIGUE (fatigue). On an unknown date, the patient experienced DYSPHONIA (change in voice). At the time of the report, VISION BLURRED (blurry vision), DIZZINESS (light headed), FATIGUE (fatigue) and DYSPHONIA (change in voice) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness on her left arm, like 3 inches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. No Medical History information was reported. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ERYTHEMA (redness on her left arm, like 3 inches). At the time of the report, ERYTHEMA (redness on her left arm, like 3 inches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity, Vaccination site pruritus, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (discomfort at the injection site), INJECTION SITE PAIN (tenderness), VACCINATION SITE RASH (big red rash, near the site inject), PAIN IN EXTREMITY (COVID arm) and VACCINATION SITE PRURITUS (itchy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (discomfort at the injection site), INJECTION SITE PAIN (tenderness), VACCINATION SITE RASH (big red rash, near the site inject), PAIN IN EXTREMITY (COVID arm) and VACCINATION SITE PRURITUS (itchy). At the time of the report, INJECTION SITE PAIN (discomfort at the injection site), INJECTION SITE PAIN (tenderness), VACCINATION SITE RASH (big red rash, near the site inject), PAIN IN EXTREMITY (COVID arm) and VACCINATION SITE PRURITUS (itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: not able to move his arm; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (not able to move his arm) and MYALGIA (soreness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (not able to move his arm) and MYALGIA (soreness). At the time of the report, PAIN IN EXTREMITY (not able to move his arm) and MYALGIA (soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No irrelevant concomitant medication were reported
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Erythema, Fatigue, Feeling hot
Clinical narrative: hot rash; swollen rash; chills; fever; fatigue; rash from shoulder to elbow; rash on arm; itchy rash on arm; redness; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and RASH (rash from shoulder to elbow) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A or MRN4544) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced RASH (rash from shoulder to elbow). On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) and RASH (rash from shoulder to elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Rash pruritic, Swelling
Clinical narrative: hot rash; swollen rash; chills; fever; fatigue; rash from shoulder to elbow; rash on arm; itchy rash on arm; redness; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and RASH (rash from shoulder to elbow) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A or MRN4544) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced RASH (rash from shoulder to elbow). On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) and RASH (rash from shoulder to elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, COVID-19, Chills, Decreased appetite
Clinical narrative: throw-up; Feeling cold; Did not eat for two days; arm redness and swollen at the injection site; arm redness and swollen at the injection site; Chills; Fever; Nausea; Tired; Stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Tired) and ABDOMINAL PAIN UPPER (Stomach ache). On an unknown date, the patient experienced VOMITING (throw-up), FEELING COLD (Feeling cold) and DECREASED APPETITE (Did not eat for two days). In January 2021, VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), NAUSEA (Nausea), FATIGUE (Tired) and ABDOMINAL PAIN UPPER (Stomach ache) was resolving. On 24-Jan-2021, CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, VOMITING (throw-up), FEELING COLD (Feeling cold) and DECREASED APPETITE (Did not eat for two days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, COVID-19: positive tested positive.. On 22-Jan-2021, Body temperature: 101 °F High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Nausea, Pyrexia, Vaccination site erythema
Clinical narrative: throw-up; Feeling cold; Did not eat for two days; arm redness and swollen at the injection site; arm redness and swollen at the injection site; Chills; Fever; Nausea; Tired; Stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Tired) and ABDOMINAL PAIN UPPER (Stomach ache). On an unknown date, the patient experienced VOMITING (throw-up), FEELING COLD (Feeling cold) and DECREASED APPETITE (Did not eat for two days). In January 2021, VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), NAUSEA (Nausea), FATIGUE (Tired) and ABDOMINAL PAIN UPPER (Stomach ache) was resolving. On 24-Jan-2021, CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, VOMITING (throw-up), FEELING COLD (Feeling cold) and DECREASED APPETITE (Did not eat for two days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, COVID-19: positive tested positive.. On 22-Jan-2021, Body temperature: 101 °F High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vomiting
Clinical narrative: throw-up; Feeling cold; Did not eat for two days; arm redness and swollen at the injection site; arm redness and swollen at the injection site; Chills; Fever; Nausea; Tired; Stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Tired) and ABDOMINAL PAIN UPPER (Stomach ache). On an unknown date, the patient experienced VOMITING (throw-up), FEELING COLD (Feeling cold) and DECREASED APPETITE (Did not eat for two days). In January 2021, VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), NAUSEA (Nausea), FATIGUE (Tired) and ABDOMINAL PAIN UPPER (Stomach ache) was resolving. On 24-Jan-2021, CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, VOMITING (throw-up), FEELING COLD (Feeling cold) and DECREASED APPETITE (Did not eat for two days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, COVID-19: positive tested positive.. On 22-Jan-2021, Body temperature: 101 °F High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.